Skip to Main Content

Paper Details

Genetic and epigenetic profiling of CLL disease progression reveals limited somatic evolution and suggests a relationship to memory-cell development.
Blood Cancer J
25
2015
CLL, CpG, CpG sites, CpGs, PRC2, PRC2 targets, Polycomb 2 repressive complex, Progression-associated CpGs, chronic lymphocytic leukemia, leukemia, memory B cells, memory-cell, naive, normal memory B cells, patients
Author NameAffiliation
Erin N Smith1] Pediatrics and Rady's Children's Hospital, University of California at San Diego, USA [2] Moores Cancer Center
Christopher DeBoeverUniversity of California at San Diego
Laura Z Rassenti1] Moores Cancer Center, University of California at San Diego
Kristen JepsenInstitute for Genomic Medicine, University of California at San Diego
Kristen JepsenInstitute for Genomic Medicine, University of California at San Diego
Sophie Rozenzhak1] Pediatrics and Rady's Children's Hospital, University of California at San Diego, USA [2] Moores Cancer Center
Mahdieh KhosroheidariInstitute for Genomic Medicine, University of California at San Diego
Kevin L GundersonInc.
Karen MesserMoores Cancer Center, University of California at San Diego
Lakshmi Muthuswamy1] Ontario Institute for Cancer Research, University of Toronto
Thomas J Hudson1] Ontario Institute for Cancer Research, University of Toronto
Thomas J Hudson1] Ontario Institute for Cancer Research, University of Toronto
Olivier Harismendy1] Pediatrics and Rady's Children's Hospital, University of California at San Diego, USA [2] Moores Cancer Center
Thomas J Kipps1] Moores Cancer Center, University of California at San Diego
Kelly A Frazer1] Pediatrics and Rady's Children's Hospital, University of California at San Diego, USA [2] Moores Cancer Center, USA [4] Institute for Genomic Medicine
Kelly A Frazer1] Pediatrics and Rady's Children's Hospital, University of California at San Diego, USA [2] Moores Cancer Center, USA [4] Institute for Genomic Medicine
  • 1 - 16

Datasets

Release 1.2